VEGFR

VEGFR 包括三种亚型:fms 样酪氨酸激酶 Flt-1 (VEGFR1/Flt-1)、激酶结构域区域(也称为胎儿肝激酶)(VEGFR2/KDR/Flk-1) 和 Flt-4 (VEGFR3)。每个受体在胞外结构域中有七个免疫球蛋白样结构域、一个跨膜区域和一个由激酶插入结构域中断的一致酪氨酸激酶序列。VEGFR1 和 2 在血管内皮细胞上表达,而 VEGFR3 在淋巴管内皮细胞上表达。VEGF 家族成员 VEGF-A、-B、-C、-D、-E 和 PlGF 以及人类免疫缺陷 (HIV) Tat 蛋白以特定模式与三种相关受体蛋白酪氨酸激酶 VEGFR1、2 和 3 结合,并诱导同源和异源受体复合物的形成。VEGF 与 VEGFR 的结合会导致受体二聚化和自身磷酸化。与 VEGFR 特定酪氨酸残基相关的细胞内蛋白(如 VEGFR 相关蛋白 (VRAP)、PLC 和 Sck)在受体激活后被磷酸化。VEGF 与其受体结合可激活多种信号转导途径,从而导致细胞增殖、存活、通透性和迁移增加。

VEGFRs consist of three subtypes, the fms-like tyrosine kinase Flt-1 (VEGFR1/Flt-1), the kinase domain region, also referred to as fetal liver kinase (VEGFR2/KDR/Flk-1), and Flt-4 (VEGFR3). Each receptor has seven immunoglobulinlike domains in the extracellular domain, a single transmembrane region, and a consensus tyrosine kinase sequence interrupted by a kinase insert domain. VEGFR1 and 2 are expressed on vascular endothelial cells, whereas VEGFR3 is expressed on lymphatic endothelial. The VEGF family members VEGF-A, -B, -C, -D, -E, and PlGF, and the human immunodeficiency (HIV) Tat protein bind in specific patterns to three related receptor protein tyrosine kinases, VEGFR1, 2, and 3, and induce the formation of homo- and heteromeric receptor complexes. Binding of VEGF to VEGFR causes dimerization and autophosphorylation of the receptor. Intracellular proteins such as VEGFR-associated protein (VRAP), PLC, and Sck that associate with specific tyrosine residues of VEGFR are phosphorylated upon receptor activation. Several signal transduction pathways are activated by the binding of VEGF to its receptor, leading to increased proliferation, survival, permeability, and migration of cells.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Mersalyl
Salirgan; Salurin; Salyrgan

Mersalyl (Salirgan) 是一种有效的血管内皮生长因子 (VEGF) 和缺氧诱导因子 1 (HIF-1) 诱导剂,可诱导 VEGF 和 ENO1 mRNA 表达,并具有利尿作用。

492-18-2
Inducer
89.25%
汞撒利

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础